Burghardt, K.J.; Burghardt, P.R.; Howlett, B.H.; Dass, S.E.; Zahn, B.; Imam, A.A.; Mallisho, A.; Msallaty, Z.; Seyoum, B.; Yi, Z.
Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers. Biomedicines 2024, 12, 1057.
https://doi.org/10.3390/biomedicines12051057
AMA Style
Burghardt KJ, Burghardt PR, Howlett BH, Dass SE, Zahn B, Imam AA, Mallisho A, Msallaty Z, Seyoum B, Yi Z.
Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers. Biomedicines. 2024; 12(5):1057.
https://doi.org/10.3390/biomedicines12051057
Chicago/Turabian Style
Burghardt, Kyle J., Paul R. Burghardt, Bradley H. Howlett, Sabrina E. Dass, Brent Zahn, Ahmad A. Imam, Abdullah Mallisho, Zaher Msallaty, Berhane Seyoum, and Zhengping Yi.
2024. "Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers" Biomedicines 12, no. 5: 1057.
https://doi.org/10.3390/biomedicines12051057
APA Style
Burghardt, K. J., Burghardt, P. R., Howlett, B. H., Dass, S. E., Zahn, B., Imam, A. A., Mallisho, A., Msallaty, Z., Seyoum, B., & Yi, Z.
(2024). Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers. Biomedicines, 12(5), 1057.
https://doi.org/10.3390/biomedicines12051057
